OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
March 02, 2006
A new FDA policy emphasizes quality control over GMP compliance in producing clinical trial supplies.
February 02, 2006
FDA is proposing revisions to the drug user fee program while it weighs changes for drug safety initiatives and expanded vaccine production.
January 01, 2006
Manufacturers, FDA, and research organizations are collaborating on efforts to spur innovation and streamline drug production.
December 02, 2005
CDER is reorganizing staffs and developing new policies to encourage industry adoption of quality production systems.
November 02, 2005
New leadership must address political and scientific issues as the Medicare drug benefit alters manufacturer incentives.
October 06, 2005
von Eschenbach Drops NCI Hat…for Now